Short Implants in the posterior jaw: a clinical study - ZB-SI

Danube Private University GmbH (DPU)0 个研究点目标入组 40 人开始时间: 2021年5月21日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Sane adults, i.e., patients capable of giving consent
•- Good general health (ASA = 2 [32])
•a. Diabetes mellitus should be well controlled (HbA1c <7)
•b. Smoking = 20 cigarettes / day
•c. No alcohol or drug abuse
•- No pathology of bone metabolism
•- Patients with periodontitis should be treated successfully, i.e., no residual periodontal infection
•- Good oral hygiene and compliance, i.e., plaque level (full-mouth plaque score, FMPS) <25% and bleeding level after probing (full-mouth bleeding on probing score, FMBS) <25%
•- A 3D radiographic bone width = 8 mm and a bone height of 5 - 6 mm in the posterior maxilla or 7 - 8 mm in the posterior mandible
•A bone height in the posterior maxilla of less than 5 mm is permissible if the existing bone height - in conjunction with an internal sinus lift performed at the same time - allows sufficient primary implant stability.
•- Tooth extraction must have taken place at least three months ago
•- Existing opposing teeth
•- Patients must be willing to adhere to a prevention concept (supportive therapy, UT). This is a routine protocol.
•- Written declaration of consent to participate in this study

发起方

Danube Private University GmbH (DPU)